Atrial fibrillation (AF) is the most common form of arrythmia or irregular heartbeat worldwide, impacting millions of people in the U.S. alone.
Neumora shares sink following Phase III flop in MDD – Pharmaceutical Technology
Neumora’s share price plummeted after the company shared news on a Phase III trial failure for its lead candidate. Credit: Ground Picture via Shutterstock Neumora